Education
(B82)
IRS Verified
DX Registered
990 on File
CC2 FOREVER
Financial strength (30%)
79/100
Reliability (20%)
40/100
Effectiveness (25%)
73/100
Impact (25%)
45/100
CharityAI™ Score
Not yet evaluated
Mission Statement
CC2 Forever Foundation, a 501(c)(3) organization, was founded to raise awareness of Glioblastoma, an aggressive form of brain cancer. With the support of our donors and volunteers, we fund research efforts and engage the community through fundraising events.
Financial Overview — FY 2024
$240K
Total Revenue
$112K
Total Expenses
$340K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
99.4%
Fundraising Efficiency
0.0%
Operating Reserve
36.29x
Liability-to-Asset
0.0%
Revenue Diversification
60.8%
Compared with Peers
FY 2024
Compared with 15,968 similar organizations
(United States, Education, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
99.4% | 89.3% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
0.6% | 8.2% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
0.0% | 2.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
36.3 mo | 9.3 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
60.8% | 89.4% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
25.2% | 8.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
4.4% | 9.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
53.2% | 2.8% |
P10P90
|
Impact
1 program| Outcome / Program | People Served | Cost / Service | # Completed | Duration |
|---|---|---|---|---|
| Medical Research to find a cure or treatment for Brain Cancer/Glioblastoma | 1 | $150,000.00 | — | Lifetime |
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $240K | $112K | $340K | 99.4% | 0 |
| 2023 | $192K | $108K | $212K | 0.0% | — |
| 2022 | $133K | $27K | $128K | 0.0% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.